锌与特应性皮炎:系统综述与荟萃分析
该研究通过系统综述与荟萃分析评估锌水平/锌缺乏与特应性皮炎(AD)的关联及口服补锌的疗效,纳入14项观察性研究和2项随机对照试验(RCT)。结果显示AD患者血清、头发和红细胞锌水平显著低于对照,但锌缺乏与AD的关联不显著,且研究质量偏低。
要点
- AD患者血清、头发和红细胞锌水平均显著低于对照。
- 锌缺乏者AD风险无显著增加(OR=1.50,95%CI 0.71–3.16)。
- 口服补锌在锌缺乏AD患者中改善病情,但全体AD患者中无显著改善。
核心结论
- 低血清、头发和红细胞锌水平与AD相关,但纳入研究质量偏低,结果解读受限。
研究设计与样本
- 系统综述与荟萃分析,纳入14项观察性研究和2项RCT。
主要发现
- AD患者血清锌水平显著低于对照(SMD 0.66,95%CI 0.21–1.10,P=0.004)。
- AD患者头发锌水平显著低于对照(SMD 0.95,95%CI 0.38–1.52,P=0.001)。
- AD患者红细胞锌水平显著低于对照(SMD 0.95,95%CI 0.38–1.52,P=0.001)。
- 锌缺乏者AD风险无显著增加(OR=1.50,95%CI 0.71–3.16,P=0.28)。
- 一项RCT显示锌缺乏AD患者口服补锌后病情改善,另一项RCT显示全体AD患者无显著改善。
关键数值与推荐
- 所有纳入研究质量低或中等。
临床怎么用
- 对AD患者可关注锌水平,但现有证据不足以推荐常规补锌治疗或预防AD。
局限性
- 纳入研究质量偏低,影响结果解读。
- 需要高质量观察性研究确认低锌与AD的关联。
- 需要RCT评估补锌对AD治疗或预防的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Zinc plays a central role in skin integrity via barrier and immune mechanisms and may also be relevant in the pathogenesis of atopic dermatitis (AD). However, little is known about the relationship between zinc and AD. We performed a systematic review to determine (i) the association between zinc levels or zinc deficiency and AD and (ii) the efficacy of oral zinc supplementation in the treatment of AD. We searched PubMed, Scopus, Web of Science and article references for observational studies on zinc levels or zinc deficiency in participants with AD vs. controls and for randomized control trials (RCTs) on zinc supplementation in AD. For observational studies, we calculated pooled standardized mean differences (SMDs) or odds ratios (ORs) along with 95% confidence intervals (CIs) using a random effects model. We included 14 observational studies and two RCTs. The pooled SMD demonstrated significantly lower serum (SMD 0.66, 95% CI 0.21-1.10, P = 0.004), hair (SMD 0.95, 95% CI 0.38-1.52, P = 0.001) and erythrocyte (SMD 0.95, 95% CI 0.38-1.52, P = 0.001) zinc levels in participants with AD compared to controls. Pooled unadjusted data from three studies showed a non-significant increased odds of AD in those with zinc deficiency compared with those without zinc deficiency (OR = 1.50, 95% CI 0.71-3.16, P = 0.28). One RCT of oral zinc supplementation among AD patients with zinc deficiency showed improvement in extent and severity of AD, while another RCT among all AD patients showed no significant improvement. All the studies were of low or moderate quality. We conclude that low serum, hair and erythrocyte zinc levels are associated with AD. However, the poor quality of included studies makes interpretation of these results problematic. High-quality observational studies are needed to confirm the association between low zinc levels and AD, and RCTs are required to evaluate the merit of zinc supplementation for the treatment or prevention of AD.
引用
- Gray NA, Dhana A, Stein DJ, et al. Zinc and atopic dermatitis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019. PMID: 30801794. doi:10.1111/jdv.15524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。